These guidelines suggest evaluation, therapy, and work-up of pneumonia patients based upon patient- specific risk factors, age and site of treatment. Pneumococcal species are the most common ...
To maximize its cash runway while the Board conducts its review of strategic alternatives, Viracta has elected to close its ongoing pivotal Phase 2 clinical trial of Nana-val in relapsed/refractory ...
A total of 11 organizations will receive money for youth substance use prevention and workforce ... system and provide them with support and treatment with the largest sum — around $625,650 ...
6 Specific goal of this clinical guideline is the prevention of further health impairment of patients (ie, recurrences) by providing recommendations for improved diagnostic and therapeutic ...